Nav: Home

Children's Research Institute at UT Southwestern research garners Stand Up To Cancer grant

April 21, 2016

Children's Research Institute at UT Southwestern research garners Stand Up To Cancer grant DALLAS - April 21, 2016 - Dr. Hao Zhu, Assistant Professor of Children's Medical Center Research Institute at UT Southwestern (CRI), is one of 10 researchers in the nation to receive a Stand Up To Cancer grant to further his studies of a gene whose absence protects mice against liver cancer and promotes liver tissue regeneration in mammals.

Stand Up To Cancer announced the $750,000 grant - awarded to early-career scientists to support innovative, high-risk, high-reward projects in cancer research - at the 2016 annual meeting of the American Association for Cancer Research. Stand Up To Cancer raises funds to accelerate the pace of research to get new therapies to patients quickly.

"I am extremely fortunate to have been awarded this Stand Up To Cancer grant, which will allow my laboratory to test high-risk ideas that may make an impact on liver cancer, an otherwise devastating disease," said Dr. Zhu, Assistant Professor of Pediatrics and Internal Medicine at UT Southwestern Medical Center, whose lab is working to understand the mechanisms shared by cancer and organ regeneration.

In mammals, there is a strong association of cancer with chronic damage to the skin, intestine, and liver. Dr. Zhu's work focuses on a gene called Arid1a, which has been associated with cancer. In a study recently published in Cell Stem Cell, Dr. Zhu found that genetic deletion of Arid1a in mice profoundly increases the healing capacity of the liver after injury without increasing cancer. Deletion of this gene protected mice against liver cancer.

His research aims to understand the relationship between injury, regeneration, and cancer and more specifically to investigate Arid1a, and its related biological pathways, as new therapeutic targets in tissue repair and cancer. The hypothesis of the Stand Up To Cancer project is that blocking regeneration by suppressing genes like Arid1a will promote tissue regeneration and prevent or delay carcinogenesis.

The projects are characterized as "high-risk" because they challenge existing paradigms, utilize novel concepts or approaches, and because applicants are not required--as they would be by most conventional funding mechanisms--to have already conducted a portion of the research resulting in an established base of evidence. If successful, the projects have the potential for "high-reward" in terms of saving lives.

"Dr. Zhu's research is providing important new insights into cancer biology. His drive to translate his findings to patients and his collaborative approach to science make him a valued member of Children's Research Institute. We are proud that the grant from Stand Up To Cancer will further his important work." said Dr. Sean Morrison, CRI Director, Professor of Pediatrics at UT Southwestern, and a Howard Hughes Medical Institute Investigator. Dr. Morrison holds the Mary McDermott Cook Chair in Pediatric Genetics.

The National Cancer Institute (NCI) reports that liver cancer deaths increased at the highest rate of all common cancers from 2003-2012. In addition to cirrhosis, risk factors for liver cancer include infections caused by the hepatitis C virus (HCV), liver damage from alcohol or other toxins, chronic liver disease, and certain rare genetic disorders.

Dr. Zhu, a Cancer Prevention Research Institute of Texas (CPRIT) Scholar in Cancer Research and member of UT Southwestern's Harold C. Simmons Comprehensive Cancer Center, was selected for the Stand Up To Cancer grant from among 250 applicants. He is the second UT Southwestern faculty member to be awarded a grant from the organization. In 2011, Dr. Angelique Whitehurst, Assistant Professor in the Simmons Comprehensive Cancer Center and Pharmacology, was awarded a Stand Up To Cancer grant for her work to characterize the mechanisms that permit uncontrolled growth of tumor cells.

The Harold C. Simmons Comprehensive Cancer Center is the only NCI-designated Comprehensive Cancer Center in North Texas and one of just 45 NCI-designated Comprehensive Cancer Centers in the nation. The Simmons Cancer Center includes 13 major cancer care programs with a focus on treating the whole patient with innovative treatments, while fostering groundbreaking basic research that has the potential to improve patient care and prevention of cancer worldwide. In addition, the Center's education and training programs support and develop the next generation of cancer researchers and clinicians.
About CRI

Children's Medical Center Research Institute at UT Southwestern (CRI) is a joint venture established in 2011 to build upon the internationally recognized scientific excellence of UT Southwestern Medical Center and the comprehensive clinical expertise of Children's Medical Center, the flagship hospital of Children's Health?. CRI's mission is to perform transformative biomedical research to better understand the biological basis of disease, seeking breakthroughs that can change scientific fields and yield new strategies for treating disease. Located in Dallas, Texas, CRI is creating interdisciplinary groups of exceptional scientists and physicians to pursue research at the interface of regenerative medicine, cancer biology and metabolism, fields that hold uncommon potential for advancing science and medicine. More information about CRI is available on its website.

To automatically receive news releases from UT Southwestern via email, subscribe at

UT Southwestern Medical Center

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".